EMBC - Embecta Corp logo

EMBC

Embecta Corp

Net -8.28%top 1%Rev -5.71%top 1%1Y
Hold

Embecta Corp. designs and manufactures medical devices for diabetes management, including pen needles, syringes, and safety injection devices. The company sells primarily to wholesalers and distributors, focusing on improving health and wellbeing for diabetics.

โš•๏ธ Healthcare NASDAQ Listed 2022 $ USD
$1,000 invested 1 year ago โ†’$371today

Score Overview

1 Year
Scoreโ€”
Net Growth-8.28%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-5.71%
Rev TrendShrank
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-60.87%
Net Trend50%
Net Income Consistency
Rev Growth-9.81%
Rev Trend25%
Revenue Consistency

See the full market ranking โ†’

Embecta Corp fundamental performance

Across Embecta Corp's full reported history, from 2022 to 2025, revenue declined from $ 1.12B to $ 1.08B and net income declined from $ 223M to $ 95M. Revenue increased in 25% of the years measured; net income in 50%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.75โ€”
1 Year2025-08-12
$ 12.79-62.85%
All Time2022-04-01
$ 26.44-82.04%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 1.01B$ 87M$ 214M
2025$ 1.08B$ 95M$ 225M
2024$ 1.12B$ 78M$ 267M
2023$ 1.12B$ 70M$ 326M
IPO2022$ 1.12B$ 223M$ 330M

Explore beyond EMBC

You're looking at Embecta Corp. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies